Literature DB >> 18336559

Seizures in multiple sclerosis.

Marcus Koch1, Maarten Uyttenboogaart, Susan Polman, Jacques De Keyser.   

Abstract

Seizures have long been recognized to be part of the disease spectrum of multiple sclerosis (MS). While they occur in only a minority of patients with MS, epileptic seizures can have serious consequences. The treatment of MS can be epileptogenic, and antiepileptic treatment can conversely worsen the symptoms of MS. In this article we present an overview of the current literature on the epidemiology, clinical presentation, pathology, imaging, prognosis and treatment of epileptic seizures in MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336559     DOI: 10.1111/j.1528-1167.2008.01565.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  24 in total

Review 1.  Menopause in multiple sclerosis: therapeutic considerations.

Authors:  Riley Bove; Tanuja Chitnis; Maria Houtchens
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

2.  Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Authors:  Ikuo Tsunoda; Fumitaka Sato; Seiichi Omura; Mitsugu Fujita; Namie Sakiyama; Ah-Mee Park
Journal:  Clin Exp Neuroimmunol       Date:  2016-10-25

3.  Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?

Authors:  Nicholas E Martinez; Fumitaka Sato; Seiichi Omura; Alireza Minagar; J Steven Alexander; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2012-05-26

4.  Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

Authors:  João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

Review 5.  Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis.

Authors:  Sara Gasparini; Edoardo Ferlazzo; Michele Ascoli; Chiara Sueri; Vittoria Cianci; Concetta Russo; Laura Rosa Pisani; Pasquale Striano; Maurizio Elia; Ettore Beghi; Carmela Colica; Umberto Aguglia
Journal:  Neurol Sci       Date:  2017-01-04       Impact factor: 3.307

6.  Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center.

Authors:  Lisa Langenbruch; Julia Krämer; Sati Güler; Gabriel Möddel; Sophia Geßner; Nico Melzer; Christian E Elger; Heinz Wiendl; Thomas Budde; Sven G Meuth; Stjepana Kovac
Journal:  J Neurol       Date:  2019-05-08       Impact factor: 4.849

7.  Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.

Authors:  Khalil Kanjwal; Beverly Karabin; Yousuf Kanjwal; Blair P Grubb
Journal:  Int J Med Sci       Date:  2010-03-11       Impact factor: 3.738

8.  Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report.

Authors:  Stefano Sotgiu; Maria R Murrighile; Gabriela Constantin
Journal:  BMC Neurol       Date:  2010-09-23       Impact factor: 2.474

9.  DTI abnormalities in anterior corpus callosum of rats with spike-wave epilepsy.

Authors:  H Chahboune; A M Mishra; M N DeSalvo; L H Staib; M Purcaro; D Scheinost; X Papademetris; S J Fyson; M L Lorincz; V Crunelli; F Hyder; H Blumenfeld
Journal:  Neuroimage       Date:  2009-05-03       Impact factor: 6.556

10.  Prevalence of epilepsy/seizures as a comorbidity of neurologic disorders in nursing homes.

Authors:  Angela K Birnbaum; Ilo E Leppik; Kenneth Svensden; Lynn E Eberly
Journal:  Neurology       Date:  2017-01-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.